TY - JOUR
AU - Hawley C.
AU - Cass Alan
AU - Pilmore H.
AU - Garg A.
AU - Pascoe E.
AU - Badve S.
AU - Ierino F.
AU - Beta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study Trial Management Committee
AU - Roberts M.
AU - Tonkin A.
AB - <p>
The association between blood pressure and cardiovascular outcomes in patients undergoing hemodialysis remains controversial. This may relate in part to the technique and device used and the timing of the blood pressure measurement in relation to the hemodialysis procedure. Emerging evidence indicates that standardized hemodialysis unit blood pressure measurements or measurements obtained at home, either by the patient or using an ambulatory blood pressure monitor, may offer advantages over routine hemodialysis unit blood pressure measurements for determining cardiovascular risk and treatment. This review discusses the available evidence and implications for clinicians and clinical trials.
</p>

AD - Department of Nephrology, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
AN - 22704141
BT - American Journal of Kidney Diseases
DA - -35757923164
DP - NLM
ET - 2012/06/19
LA - Eng
N1 - Roberts, Matthew APilmore, Helen LTonkin, Andrew MGarg, Amit XPascoe, Elaine MBadve, Sunil VCass, AlanIerino, Francesco LHawley, Carmel MBeta-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study Trial Management CommitteeAm J Kidney Dis. 2012 Jun 14.
N2 - <p>
The association between blood pressure and cardiovascular outcomes in patients undergoing hemodialysis remains controversial. This may relate in part to the technique and device used and the timing of the blood pressure measurement in relation to the hemodialysis procedure. Emerging evidence indicates that standardized hemodialysis unit blood pressure measurements or measurements obtained at home, either by the patient or using an ambulatory blood pressure monitor, may offer advantages over routine hemodialysis unit blood pressure measurements for determining cardiovascular risk and treatment. This review discusses the available evidence and implications for clinicians and clinical trials.
</p>

PY - 2012
SN - 1523-6838 (Electronic)0272-6386 (Linking)
T2 - American Journal of Kidney Diseases
TI - Challenges in Blood Pressure Measurement in Patients Treated With Maintenance Hemodialysis
ER -